You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Moderna submits its COVID-19 vaccine booster to the FDA

Moderna has initiated its submission to the US Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine mRNA-1273.